MAP2 and Alzheimer disease: When microtubule-associated protein 2 (MAP2, a marker of neuronal differentiation) is used as a reference gene, the expression levels of both MAO-A and MAO-B in the brains of patients with AD are 1.6 times greater than those in the brains of healthy subjects [77].